673 — China Health Income Statement
0.000.00%
Last trade - 00:00
- HK$421.52m
- HK$430.14m
- HK$76.41m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 32.2 | 45.2 | 87.9 | 107 | 76.4 |
Cost of Revenue | |||||
Gross Profit | 16.1 | 17.3 | 26 | 28.7 | 27.2 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 52.1 | 79.4 | 92.9 | 115 | 110 |
Operating Profit | -19.9 | -34.2 | -5.04 | -8.42 | -33.2 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -19.9 | -34.3 | -5.33 | -8.71 | -39.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -23 | -35.8 | -6.56 | -9.11 | -39.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -23.1 | -36.7 | -7.74 | -12.2 | -42 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -23.1 | -36.7 | -7.74 | -12.2 | -42 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.051 | -0.068 | -0.019 | -0.03 | -0.099 |